Form 4 for GH Guardant Health, Inc.
Accepted 2025-09-03 00:00:00 ET · period of report 2025-09-01 · accession 0001737840-25-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-03 | 2025-09-01 | GH | Saia John G. | CLO | F - Tax | $67.42 | -139 | 44.9K | -0.3% | -$9,371 |
| D | 2025-09-03 | 2025-09-01 | GH | Saia John G. | CLO | M - OptEx | $0.00 | +264 | 45.1K | +0.6% | $0 |
| D | 2025-09-03 | 2025-09-01 | GH | Saia John G. | CLO | M - OptEx | $0.00 | -264 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-01 | F | D | 139 | $67.42 | 44,948 | D | — | — | (F1) Not applicable for Restricted Stock Units. |
| 2 | Common | Common Stock | 2025-09-01 | M | A | 264 | $0.00 | 45,087 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2025-09-01 | M | D | 264 | $0.00 | 0 | D | $0.00 · — to — | 264 Common Stock | (F2) The restricted stock unit award was granted on November 2, 2021, and vested 25% of the shares subject to such award on September 1, 2022. The remaining 75% of the shares subject to such award vests in equal installments on each quarterly anniversary of September 1, 2022 during the three-year period thereafter. (F1) Not applicable for Restricted Stock Units. |